These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37579388)

  • 1. The Dynamics of Power Flow From the Global Health Financing Comment on "Power Dynamics Among Health Professionals in Nigeria: A Case Study of the Global Fund Policy Process".
    Brown GW; Rhodes N
    Int J Health Policy Manag; 2023; 12():7806. PubMed ID: 37579388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in international health financing and implications for the new pandemic fund.
    Brown GW; Rhodes N; Tacheva B; Loewenson R; Shahid M; Poitier F
    Global Health; 2023 Dec; 19(1):97. PubMed ID: 38053177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Situating Biomedical and Professional Monopoly at the Intersections of Structural, Ideational and Agentic Power Comment on "Power Dynamics Among Health Professionals in Nigeria: A Case Study of the Global Fund Policy Process".
    Kapilashrami A
    Int J Health Policy Manag; 2023; 12():8019. PubMed ID: 37579361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical Dominance in Global Health Institutions as an Obstacle to Equity and Effectiveness Comment on "Power Dynamics Among Health Professionals in Nigeria: A Case Study of the Global Fund Policy Process".
    Dalglish SL; Sanuade OA; Topp SM
    Int J Health Policy Manag; 2023; 12():7734. PubMed ID: 37579487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of the Global Fund to Fight AIDS, Tuberculosis and Malaria in the development of global health and its collaboration with China].
    Xu M
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Apr; 35(2):116-120. PubMed ID: 37253559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues].
    Kerouedan D
    Bull Soc Pathol Exot; 2010 May; 103(2):119-22. PubMed ID: 20376595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of Global Fund financing on health governance in Brazil.
    Gómez EJ; Atun R
    Global Health; 2012 Jul; 8():25. PubMed ID: 22799635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM).
    Poore P
    Health Policy Plan; 2004 Jan; 19(1):52-3; discussion 54-6. PubMed ID: 14679285
    [No Abstract]   [Full Text] [Related]  

  • 9. Governance and Health Aid from the Global Fund: Effects Beyond Fighting Disease.
    Kavanagh MM; Chen L
    Ann Glob Health; 2019 May; 85(1):. PubMed ID: 31099506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Power Dynamics Among Health Professionals in Nigeria: A Case Study of the Global Fund Policy Process.
    Lassa S; Saddiq M; Owen J; Burton C; Balen J
    Int J Health Policy Manag; 2022 Dec; 11(12):2876-2885. PubMed ID: 35461207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating operational research in programmes funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria in four sub-Saharan African countries.
    Camacho S; Maher D; Kamau EM; Saric J; Segura L; Zachariah R; Wyss K
    Global Health; 2020 Jul; 16(1):67. PubMed ID: 32711553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Global Fund to fight HIV/AIDS, TB and malaria policy issues].
    Kerouedan D
    Med Trop (Mars); 2010 Feb; 70(1):19-27. PubMed ID: 20337110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coloniality, Elite Networks and Intersectionality: Key Concepts in Understanding Biomedical Power and Equity in Health Policy Processes Comment on "Power Dynamics Among Health Professionals in Nigeria: A Case Study of the Global Fund Policy Process".
    Parashar R; Sriram V; Nanda S; Shekhawat F
    Int J Health Policy Manag; 2023; 12():7916. PubMed ID: 37579392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative financing instruments for global health 2002-15: a systematic analysis.
    Atun R; Silva S; Knaul FM
    Lancet Glob Health; 2017 Jul; 5(7):e720-e726. PubMed ID: 28619230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global fund financing to the 34 malaria-eliminating countries under the new funding model 2014-2017: an analysis of national allocations and regional grants.
    Zelman B; Melgar M; Larson E; Phillips A; Shretta R
    Malar J; 2016 Feb; 15():118. PubMed ID: 26911998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GFATM (Global Fund to Fight AIDS, Tuberculosis, and Malaria): which countries owe, and how much?
    France T; Ooms G; Rivers B
    IAPAC Mon; 2002 May; 8(5):138, 141. PubMed ID: 12116978
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of global health governance on country health systems: the case of HIV initiatives in Nigeria.
    Chima CC; Homedes N
    J Glob Health; 2015 Jun; 5(1):010407. PubMed ID: 25969731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance-based financing at the Global Fund to Fight AIDS, Tuberculosis and Malaria: an analysis of grant ratings and funding, 2003-12.
    Fan VY; Duran D; Silverman R; Glassman A
    Lancet Glob Health; 2013 Sep; 1(3):e161-8. PubMed ID: 25104264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From conceptual pluralism to practical agreement on policy: global responsibility for global health.
    Ruger JP; Hammonds R; Ooms G; Barry D; Chapman A; Van Damme W
    BMC Int Health Hum Rights; 2015 Oct; 15():30. PubMed ID: 26510532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the Technical Review Panel of the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria: an analysis of grant recommendations.
    Schmidt-Traub G
    Health Policy Plan; 2018 Apr; 33(3):335-344. PubMed ID: 29309574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.